Pituitary Adenoma: Early Results after Gamma Knife Radiosurgery in Iran
International Clinical Neuroscience Journal,
Vol. 2 No. 4 (2015),
5 May 2016
,
Page 128-132
https://doi.org/10.22037/icnj.v2i4.12339
Abstract
Purpose: To study early treatment outcomes and complications of Gamma Knife Radiosurgery
(GKRS) in patients with functional and nonfunctional adenomas.
Methods: One hundred patients with a pituitary adenoma who were treated between 2011 and
2014 at Iran Gamma Knife Center were studied. The patients were followed up at least 2 years.
Radiosurgery was performed using the Leksell Gamma Unit. The median radiation dose was
18 Gy for non-functional and 24 Gy for functional adenoma. The MRI were compared pre and
post operation for any change in tumor size. Endocrine follow up was used to determine the
onset of new hormone deficiency when available or decrease in hormonal level.
Results: Our study group comprised 42 men (42%) and 58 women (58%). Ninety-three patients
were treated for recurrent or residual disease after Trans-sphenoidal surgery or craniotomy and 7
patients were treated as primary modality because of extensive involvement of cavernous sinus or
high risk for surgery. Forty-six patients (46%) had a diagnosis nonfunctional and 54 of patients
(54%) had hormone-secreting tumors including growth hormone secreting (23%), prolactinoma
(15%) and ACTH-secreting tumor (6%). No mortality was reported. Acute complication was
uncommon and of no clinical significance. Late complication was noted in two patients (2%)
and consisted of VI cranial nerve palsy with spontaneous resolution. None of the patients
developed visual loss. Before GKRS, 8 patients had cranial nerve palsy. After the treatment, the
palsy resolved in six (75%) of these patients. Only 9.5% of patients developed hypopituitarism
and required replacement therapy. Overall control was 92% (28% decreased in volume and
64% were unchanged), 8% experienced an increase in volume size. Normalization of GH and
IGF-1 for GH-secreting hormone was 48% with overall control of 73%. PRL normalization for
prolactinoma was 46% with overall control of 67%. ACTH normalization for ACTH-secreting
hormone was 35% with overall control of 70%.
Conclusion: It seems that GKRS to be safe and effective method for tumor control and optimal
hormonal function.
- Pituitary Adenoma
- Gamma Knife
- Radiosurgery
- Iran
How to Cite
References
Laws ER Jr, Vance ML. Radiosurgery for pituitary tumors and craniopharyngiomas. Neurosurg Clin N Am 10:327–336, 1999.
Petrovich Z, Jozsef G, Yu C, Apuzzo MLJ. Radiotherapy and stereotactic radiosurgery for pituitary tumors. Neurosurg Clin N Am 14:147–166, 2003.
Landolt AM, Lomax N. Gamma knife radiosurgery for prolactinomas. J Neurosurg 93[Suppl 3]:14–18, 2000.
Landolt AM, Haller D, Lomax N, Scheib S, Schubiger O, Siegfried J, et al. Stereotactic radiosurgery for recurrent surgically treated acromegaly: Comparison with fractionated radiotherapy. J Neurosurg 88:1002–1008, 1998.
Inoue HK, Kohga H, Hirato M, Sasaki T, Ishihara J, Shibazaki T, et al. Pituitary adenomas treated by microsurgery with or without Gamma Knife surgery: Experience in 122 cases. Stereotact Funct Neurosurg 72 [Suppl 1]:125–131, 1999.
Ikeda H, Jokura H, Yoshimoto T. Transsphenoidal surgery and adjuvant gamma knife treatment for growth hormone-secreting pituitary adenoma. J Neurosurg 95:285–291, 2001.
Sheehan JP, Kondziolka D, Flickinger J, Lunsford LD. Radiosurgery for residual or recurrent nonfunctioning pituitary adenoma. J Neurosurg 97:408–414, 2002.
Pamir MN, Kiliç T, Belirgen M, Abacioğlu U, Karabekiroğlu N. Pituitary adenomas treated with gammaknife radiosurgery: volumetric analysis of 100 cases with minimum 3 yearfollow-up. Neurosurgery. 2007 Aug;61(2):270-80
Langsenlehner T, Stiegler C, Quehenberger F, Feigl GC, Jakse G, Mokry M, et al. Long-term follow-up of patients with pituitary macroadenomas after postoperative radiation therapy: analysis of tumor control and functional outcome. Strahlenther Onkol. 2007 May;183(5):241-7.
Minniti G, Jaffrain-Rea ML, Osti M, Cantore G, Enrici RM. Radiotherapy for nonfunctioning pituitary adenomas: from conventional to modern stereotactic radiation techniques. Neurosurg Rev. 2007; 30(3):167-175.
Minniti G, Gilbert DC, Brada M. Modern techniques for pituitary radiotherapy. Rev Endocr Metab Disord. 2009;10 (2):135-144.
Gopalan R, Schlesinger D, Vance ML, Laws E, Sheehan J. Long-term outcomes after Gamma Knife radiosurgery for patients with a nonfunctioning pituitary adenoma. Neurosurgery. 2011 Aug;69(2):284-93.
Mak HK, Lai SW, Qian W, Xu S, Tong E, Vance ML, Oldfield E, Jane J Jr, Sheehan J, Yau KK, Wintermark M. Effective time window in reducing pituitary adenoma size by gamma knife radiosurgery, Pituitary, 2015 Aug;18 (4):509-17.
Ciric I, Ragin A, Baumgartner C, Pierce D. Complications of transsphenoidal surgery: results of a national survey, review of the literature, and personal experience. Neurosurgery. 1997;40(2):225-236; discussion 236-237.
Petrovich Z, Yu C, Giannotta SL, Zee CS, Apuzzo ML. Gamma knife radiosurgery for pituitary adenoma: early results. Neurosurgery. 2003 Jul;53(1):51-9; discussion 59-61.
Tinnel BA, Henderson MA, Witt TC, Fakiris AJ, Worth RM, Des Rosiers PM, et al. Endocrine response after gamma knife-based stereotactic radiosurgery for secretory pituitary adenoma. Stereotact Funct Neurosurg. 2008; 86(5):292-6.
Kobayashi T, Mori Y, Uchiyama Y, Kida Y, Fujitani S. Long-term results of gamma knife surgery for growth hormone-producing pituitary adenoma: is the disease difficult to cure? J Neurosurg. 2005 Jan;102 Suppl:119-23.
Mokry M, Ramschak-Schwarzer S, Simbrunner J, Ganz JC, Pendl G. A six year experience with the postoperative radiosurgical management of pituitary adenomas. Stereotact Funct Neurosurg 72[Suppl 1]:88–100, 1999.
- Abstract Viewed: 538 times
- PDF Downloaded: 924 times